Ezel Uslu

746 total citations
41 papers, 589 citations indexed

About

Ezel Uslu is a scholar working on Physiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ezel Uslu has authored 41 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 11 papers in Molecular Biology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ezel Uslu's work include Biochemical effects in animals (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Peptidase Inhibition and Analysis (4 papers). Ezel Uslu is often cited by papers focused on Biochemical effects in animals (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Peptidase Inhibition and Analysis (4 papers). Ezel Uslu collaborates with scholars based in Türkiye, United Kingdom and United States. Ezel Uslu's co-authors include Seval Aydın, Ufuk Çakatay, Pınar Atukeren, Ahmet Belce, Karolin Yanar, E Kökoğlu, Mustafa Erinç Sitar, İlhami Uslu, A. Ata Alturfan and Hafize Uzun and has published in prestigious journals such as Cancer Letters, Oxidative Medicine and Cellular Longevity and Diseases of the Colon & Rectum.

In The Last Decade

Ezel Uslu

41 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ezel Uslu Türkiye 15 159 157 94 91 68 41 589
Andrea Mangiameli Italy 12 354 2.2× 126 0.8× 115 1.2× 90 1.0× 36 0.5× 25 894
Ahmet Belce Türkiye 15 183 1.2× 123 0.8× 46 0.5× 52 0.6× 68 1.0× 32 604
Olena Oliyarnyk Czechia 18 367 2.3× 253 1.6× 146 1.6× 59 0.6× 78 1.1× 48 1.0k
Canan Küçükgergin Türkiye 17 155 1.0× 167 1.1× 55 0.6× 26 0.3× 76 1.1× 49 704
Selda Gezginci-Oktayoğlu Türkiye 16 175 1.1× 71 0.5× 146 1.6× 40 0.4× 42 0.6× 37 618
Eunhui Seo South Korea 18 388 2.4× 267 1.7× 107 1.1× 49 0.5× 46 0.7× 32 969
Steffen Daub Germany 14 255 1.6× 282 1.8× 104 1.1× 60 0.7× 106 1.6× 21 953
Enrique O’Connor Spain 11 238 1.5× 123 0.8× 69 0.7× 60 0.7× 40 0.6× 14 783
Tomi Tuomainen Finland 15 369 2.3× 129 0.8× 79 0.8× 71 0.8× 90 1.3× 25 807
S. De Luca Italy 15 207 1.3× 113 0.7× 104 1.1× 29 0.3× 72 1.1× 46 908

Countries citing papers authored by Ezel Uslu

Since Specialization
Citations

This map shows the geographic impact of Ezel Uslu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ezel Uslu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ezel Uslu more than expected).

Fields of papers citing papers by Ezel Uslu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ezel Uslu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ezel Uslu. The network helps show where Ezel Uslu may publish in the future.

Co-authorship network of co-authors of Ezel Uslu

This figure shows the co-authorship network connecting the top 25 collaborators of Ezel Uslu. A scholar is included among the top collaborators of Ezel Uslu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ezel Uslu. Ezel Uslu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uslu, Ezel, et al.. (2024). Is Serum VEGF-A Level an Indicator of Early-Onset Poststroke Depression?. Medicina. 60(11). 1828–1828. 3 indexed citations
2.
Çetin, Berna Aslan, et al.. (2021). The Association Between Follicular Fluid Sialic Acid Levels, Oocyte Quality, and Pregnancy Rates. Reproductive Sciences. 29(2). 633–638. 4 indexed citations
3.
Koruyucu, Mine, et al.. (2020). Saliva profiles in children with congenital heart disease. European Oral Research. 54(1). 48–54. 2 indexed citations
4.
Önal, Bülent, et al.. (2020). Do urinary mast cell mediators predict immune response to BCG in patients with primary high‐grade non‐muscle invasive bladder cancer?. International Journal of Clinical Practice. 75(5). e13959–e13959. 4 indexed citations
5.
Erman, Hayriye, Uğur Aksu, Ahmet Belce, et al.. (2016). Gender and chronological age affect erythrocyte membrane oxidative indices in citrate phosphate dextrose adenine-formula 1 (CPDA-1) blood bank storage condition. General Physiology and Biophysics. 35(3). 343–351. 7 indexed citations
6.
Çakatay, Ufuk, Seval Aydın, Pınar Atukeren, et al.. (2013). Increased Protein Oxidation and Loss of Protein-Bound Sialic Acid in Hepatic Tissues of D-galactose Induced Aged Rats. Current Aging Science. 6(2). 135–141. 14 indexed citations
7.
Aydın, Seval, Karolin Yanar, Pınar Atukeren, et al.. (2011). Comparison of oxidative stress biomarkers in renal tissues of d-galactose induced, naturally aged and young rats. Biogerontology. 13(3). 251–260. 48 indexed citations
8.
Yanar, Karolin, Seval Aydın, Ufuk Çakatay, et al.. (2011). Protein and DNA Oxidation in Different Anatomic Regions of Rat Brain in a Mimetic Ageing Model. Basic & Clinical Pharmacology & Toxicology. 109(6). 423–433. 64 indexed citations
9.
Atukeren, Pınar, et al.. (2010). Redox Homeostasis of Albumin in Relation to Alpha‐Lipoic Acid and Dihydrolipoic Acid. Oxidative Medicine and Cellular Longevity. 3(3). 206–213. 37 indexed citations
10.
Alturfan, A. Ata, Ebru Emekli‐Alturfan, & Ezel Uslu. (2009). Consumption of Pistachio Nuts Beneficially Affected Blood Lipids and Total Antioxidant Activity in Rats Fed a High-Cholesterol Diet. Folia Biologica. 55(4). 132–136. 16 indexed citations
11.
Eren, Gülay, Zafer Çukurova, Oya Hergünsel, et al.. (2009). Protective Effect of the Nuclear Factor Kappa B Inhibitor Pyrrolidine Dithiocarbamate in Lung Injury in Rats with Streptozotocin-Induced Diabetes. Respiration. 79(5). 402–410. 23 indexed citations
12.
Alturfan, A. Ata, Ebru Emekli‐Alturfan, & Ezel Uslu. (2009). Pistachio consumption has beneficial effects in diabetic rat model.. 23(3). 131–135. 1 indexed citations
13.
Alturfan, A. Ata, Erman Aytaç, Neslihan Balkıs, et al.. (2007). Investigation of Zinc and Copper Levels in Methimazole-Induced Hypothyroidism: Relation with the Oxidant-Antioxidant Status. Folia Biologica. 53(5). 183–188. 20 indexed citations
14.
Güven, Yegane, et al.. (2005). Salivary Malondialdehyde Levels in Patients with Oral Leukoplakia. DergiPark (Istanbul University). 4 indexed citations
15.
Uzun, Hafize, Rezzan Ataman, Seval Aydın, et al.. (2005). Serum cystatin C level as a potentially good marker for impaired kidney function. Clinical Biochemistry. 38(9). 792–798. 38 indexed citations
16.
Uslu, Ezel, et al.. (2004). The effects of ageing on brain tissue sialic acid contents following cold trauma. Acta Neurochirurgica. 146(12). 1337–1340. 5 indexed citations
17.
Uslu, Ezel, et al.. (2002). The influence of hemodialysis on serum sialic acid levels in chronic renal failure. Clinical and Experimental Nephrology. 6(3). 154–157. 2 indexed citations
18.
Uslu, Ezel, Feyza Karagöz Güzey, Deniz Güzey, Mine Kücür, & Ahmet Belce. (2002). Tissue and serum sialic acid levels in an animal head injury model.. PubMed. 8(2). 74–7. 2 indexed citations
19.
Paksoy, Melih, et al.. (2001). Influence of Pentoxifylline and Interferon-Alpha on Prevention of Stricture due to Corrosive Esophagitis. European Surgical Research. 33(3). 225–231. 11 indexed citations
20.
Kökoğlu, E, Ezel Uslu, İlhami Uslu, & H Hâtemi. (1989). Serum and tissue total sialic acid as a marker for human thyroid cancer. Cancer Letters. 46(1). 1–5. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026